2024-07-10T10:19:48-05:00 2023-12-31 910189318 MOSS ADAMS LLP 6565 AMERICAS PARKWAY NE STE 600 ALBUQUERQUE NM 87110 990 2023-01-01 204404637 KENDALL & TAYLOR ATKINSON FOUNDATION KEND 3033491309 PO BOX 3514 LITTLETON CO 801613514 JEANNE ATKINSON TREASURER 3033491309 2024-07-10 1 JEANNE ATKINSON 999009999 1 PAMELA ALEXANDERSON P01218925 5058787200 2024-06-20 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z JEANNE ATKINSON 6192 E LONG CIR SO CENTENNIAL CO 80112 242376 0 X WWW.KATAFOUNDATION.ORG X 2006 CO TO RAISE MONEY FOR CHARITABLE ALLOCATION. 8 8 0 30 0 0 162262 224375 0 0 0 0 16554 -61231 178816 163144 190000 135000 0 0 0 0 0 0 0 6451 10189 196451 145189 -17635 17955 62960 80915 0 0 62960 80915 X TO RAISE MONEY FOR CHARITABLE ALLOCATION. 0 0 135000 135000 **ALLOCATIONS WERE MADE TO THE FANCONI ANEMIA RESEARCH FUND TO SUPPORT MEDICAL, SCIENTIFIC AND TREATMENT RESEARCH OF FANCONI ANEMIA AND ITS RELATED CANCERS.*$100,000 WAS ALLOCATED TO FUND RESEARCH ENTITLED TRANSFORMING TREATMENT OF INHERITED BONE MARROW FAILURE IN FANCONI ANEMIA BY PRECISE IN VIVO GENOME EDITINGPEOPLE WITH FA, WHO HAVE BONE MARROW FAILURE, ARE CURRENTLY TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTS. HOWEVER, THESE PROCEDURES REMAIN SOMEWHAT LIMITED DUE TO HIGH COST, LACK OF APPROPRIATE DONORS IN SOME REGIONS, AND HEIGHTENED RISK OF LONG-TERM HEALTH EFFECTS SUCH AS AN INCREASED RISK OF CANCER. INVIVO GENE THERAPIES OFFER PROMISE AND GREAT POTENTIAL FOR A SAGE EASILY ACCESSIBLE, AND COST-EFFECTIVE THERAPEUTIC OPTION TO TREAT FA-RELATED BONE MARROW FAILURE THAT CAN BE USED WORLDWIDE. THIS CONSORTIUM WILL TEST GENE EDITING TECHNOLOGIES FOR ALL MAJOR FA MUTATIONS USING LABORATORY-BASED TECHNIQUES OVER THE NEXT TWO YEARS. THE GOAL IS TO RAPIDLY DEVELOP A TRANSLATIONAL PROTOCOL THAT WILL EVENTUALLY BE TESTED IN CLINICAL TRIALS.**ALLOCATIONS WERE MADE TO THE UNIVERSITY OF COLORADO FOUNDATION. *AN ALLOCATION WAS MADE TO THE UNIVERSITY OF COLORADO FOUNDATION FOR THE KENNETH R ATKINSON MD ENDOWED MEMORIAL SCHOLARSHIPDISTRIBUTION OF FUNDS WAS MADE TO AN ENDOWED SCHOLARSHIP TO BE AWARDED ANNUALLY TO A STUDENT ENROLLED IN THE SCHOOL OF MEDICINE AT THE UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS. SCHOLARSHIP IS NEED BASED WITH PREFERENCE GIVEN TO 4TH YEAR MEDICAL STUDENTS WHO PLAN ON GOING INTO PRIMARY CARE MEDICINE. PREFERENCE WILL ALSO BE GIVEN TO STUDENTS INTENDING TO PRACTICE PRIMARY CARE IN THE STATE OF COLORADO.**ALLOCATIONS WERE MADE TO CAMP BARNABAS*AN ALLOCATION OF $17,500 WAS MADE TO CAMP BARNABAS IN SOUTHWEST MISSOURI TO ENHANCE THE CAMP EXPERIENCE FOR KIDS WITH SPECIAL NEEDS AND TO MEET THE MEDICAL NEEDS OF ALL CAMPERS.CAMP BARNABAS PROVIDES A UNIQUE CAMP EXPERIENCE FOR INDIVIDUALS WITH SPECIAL NEEDS. THE CAMP WANTS ITS CAMPERS TO HAVE A SUMMER JUST LIKE EVERYONE ELSE BECAUSE, FOR MOST OF THE YEAR, ITS CAMPERS ARE ON THE OUTSIDE. SPECIAL NEEDS INDIVIDUALS SPEND THEIR YEAR ADAPTING AND MAKING MODIFICATIONS TO THEIR LIVES AND ROUTINES IN ORDER TO FUNCTION IN THE WORLD AROUND THEM. CAMP BARNABAS WANTS CAMPERS TO FEEL LIMITLESS AND TO CREATE A PLACE WHERE THEY CAN FEEL THE FREEDOM TO BE WHO THEY WERE DESIGNED TO BE. THE CAMP INCLUDES AN ONSITE MEDICAL FACILITY WITH NURSES AND DOCTORS TO ACCOMMODATE THE MEDICAL NEEDS OF ITS CAMPERS. 135000 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 8 8 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 CO X JEANNE ATKINSON 3033491309 6192 E LONG CIR SO CENTENNIAL CO 80112 X STEVE RICE PRESIDENT 4.00 X X 0 0 0 JEANNE ATKINSON TREASURER 4.00 X X 0 0 0 SHELLY BEARD SECRETARY 4.00 X X 0 0 0 RICHARD DICK BEARD BOARD MEMBER 4.00 X 0 0 0 ANGIE RICE BOARD MEMBER 4.00 X 0 0 0 ADAM SANDS BOARD MEMBER 4.00 X 0 0 0 LINDA JOY WURTZBACHER BOARD MEMBER 4.00 X 0 0 0 MATT WURTZBACHER BOARD MEMBER 4.00 X 0 0 0 0 0 0 0 0 0 0 0 174824 49551 224375 17982 174824 79232 -61250 -61250 19 19 19 163144 0 0 -61231 135000 135000 3057 3057 1124 1124 299 299 1400 1400 MISCELLANEOUS OPERATION 4309 4309 145189 135000 10189 0 62960 80915 62960 80915 0 0 X 62960 80915 62960 80915 62960 80915 17955 0 X 0 0 0 X 329121 190428 229515 162262 224375 1135701 329121 190428 229515 162262 224375 1135701 363311 772390 99 193 0 292 116 19 135 1136128 173532 0.67980 0.72020 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2020 AMOUNT: $ 116. 2023 AMOUNT: $ 19. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED BARN DINNER 84421 71471 12950 222 7886 15600 5600 27109 HOPE FLOATS 63811 63811 10958 242 2 44574 39542 5032 8421 2710 484 192806 174824 17982 19601 7886 18310 5600 27835 79232 -61250 1 FANCONI ANEMIA RESEARCH FUND 1801 WILLIAMETTE SUITE 200 EUGENE OR 97401 930995453 501(C)(3) 100000 0 TO SUPPORT SCIENTIFIC, MEDICAL, AND TREATMENT RESEARCH OF FANCONI ANEMIA AND ITS RELATED CANCERS AND TO PROVIDE EDUCATION AND SUPPORT SERVICES TO AFFECTED FAMILIES. UNIVERSITY OF COLORADO FOUNDATION 1800 N GRANT ST STE 725 DENVER CO 80203 846049811 501(C)(3) 17500 0 KENNETH R ATKINSON MD ENDOWED MEMORIAL SCHOLARSHIP CAMP BARNABAS PO BOX 3200 SPRINGFIELD MO 65808 431700240 501(C)(3) 17500 0 CAMP BARNABAS 3 0 PART IV LINE 2 THE BOARD ANNUALLY ASKS FOR AND RECEIVES AN UPDATE ON THE PROGRESS OF THE RESEARCH THAT WAS FUNDED FOR ALL YEARS. IN THE CASE OF NON-RESEARCH FUNDING, THE MONITORING VARIES DEPENDING ON THE PROJECT FUNDED. FORM 990, PART VI, SECTION A, LINE 2 STEVE RICE, BOARD PRESIDENT, AND ANGIE RICE, BOARD MEMBER, FAMILY RELATIONSHIP SHELLY BEARD, BOARD SECRETARY, AND RICHARD BEARD, BOARD MEMBER, FAMILY RELATIONSHIP LINDA JOY WURTZBACHER AND MATT WURTZBACHER, BOARD MEMBERS, FAMILY RELATIONSHIP FORM 990, PART VI, SECTION B, LINE 11B COPIES OF THE FORM 990 ARE PROVIDED TO THE BOARD MEMBERS FOR REVIEW BEFORE FILING, EITHER AT A BOARD MEETING OR VIA E-MAIL. FORM 990, PART VI, SECTION B, LINE 12C AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE CORPORATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE CORPORATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.